In addition, S1P can reduce mesangial cell inflammation through the SphK1 and S1PR2 pathways, reduce renal damage, and regulate glucose excretion, indicating that S1P also has a positive effect on the prevention and treatment of T2DM complications. This evidence concerns the gene SPHK1 and type 2 diabetes mellitus.